J. Thomas

发表

The pharmacokinetics of subcutaneous regular insulin in type I diabetic patients: assessment using a glucose clamp technique.

R. Arakaki, L. J. Nell, J. Field, 1986, The Journal of clinical endocrinology and metabolism.

Frequency and Specificity of Protamine Antibodies in Diabetic and Control Subjects

James W. Thomas, L. J. Nell, J. Thomas, 1988, Diabetes.

Factors affecting the insulin autoantibody ELISA.

D. Rogers, J. Comstock, R. Arem, 1989, Autoimmunity.

Prolonged action of regular insulin in diabetic patients: lack of relationship to circulating insulin antibodies.

R. Arakaki, M. Crane, L. J. Nell, 1986, The Journal of clinical endocrinology and metabolism.

Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways.

J. Giri, M. Huynh, P. Doshi, 2001, Experimental hematology.

Expression and functional expansion of fibroblast growth factor receptor T cells in rheumatoid synovium and peripheral blood of patients with rheumatoid arthritis.

G. Miller, W. Mckeehan, X. Zhao, 1996, Arthritis and rheumatism.

Preference for IgG mAb binding insulin in solution or on surfaces is related to immunoglobulin variable region structures.

O. Tikhomirov, J. Thomas, O.Yu Tikhomirov, 1997, Journal of autoimmunity.

Genetic origin of human anti-insulin antibodies.

M. Beckwith, L. J. Nell, J. Thomas, 1989, Human immunology.

Application of a Rapid Enzyme-linked Immunosorbent Microassay (ELISA) to Study Human Anti-insulin Antibody

L. J. Nell, J. Thomas, V. J. Virta, 1985, Diabetes.

Macrophage-lymphocyte interaction and genetic control of immune responsiveness.

K. Yokomuro, J. T. Blake, J. Schroer, 1979, Advances in experimental medicine and biology.

CD11b+CD28-CD4+ human T cells: activation requirements and association with HLA-DR alleles.

G. Nepom, G. Miller, S. Stewart, 1996, Journal of immunology.

Monoclonal antibody to rubella virus capsid protein recognizes a beta-cell antigen.

J. Wolinsky, J. Thomas, D. Karounos, 1993, Journal of immunology.

Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3.

C. Baum, J. Monahan, M. Abrams, 1995, Proceedings of the National Academy of Sciences of the United States of America.

T cells recognize both conformational and cryptic determinants on the insulin molecule

James W. Thomas, W. Danho, J. Thomas, 1989, European journal of immunology.

B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice.

M. Rojas, J. Thomas, C. Hulbert, 2001, Journal of immunology.

Recognition of Common Islet Antigen by Autoantibodies From NOD Mice and Humans With IDDM

J. Thomas, D. Karounos, 1990, Diabetes.

Autoantibodies present at onset of type I diabetes recognize multiple islet cell antigens.

L. J. Nell, J. Thomas, D. Karounos, 1990, Autoimmunity.

Insulin B chain functions as an effective competitor of antigen presentation via peptide homologies present in the thymus

G. Miller, J. Thomas, J. Hoy, 1989, The Journal of experimental medicine.

Immune response gene control of determinant selection. III. Polypeptide fragments of insulin are differentially recognized by T but not by B cells in insulin immune guinea pigs.

W. Danho, A. Rosenthal, E. Bullesbach, 1981, Journal of immunology.

Insulin-specific human T cells. Epitope specificity, major histocompatibility complex restriction, and alloreactivity to a diabetes-associated haplotype.

James W. Thomas, G. Miller, M. Pollack, 1987, Journal of immunology.

Cytotoxic properties of DAB486EGF and DAB389EGF, epidermal growth factor (EGF) receptor-targeted fusion toxins.

J. Shaw, B. Sullivan, J. Nichols, 1991, The Journal of biological chemistry.

Genetic control of the immune response to insulin: its dependence upon a macrophage mediated selection of distinct antigenic sites.

L. Rosenwasser, J. T. Blake, J. Schroer, 1978, Advances in Experimental Medicine and Biology.

Nucleotide sequences of eight human natural autoantibody VH regions reveals apparent restricted use of VH families.

J. D. Capra, P. Casali, I. Sanz, 1989, Journal of immunology.

Antibodies against ganglioside GT3 in the sera of patients with type I diabetes mellitus.

L. J. Nell, D. Marcus, B. Gillard, 1989, Journal of immunology.

Failure of antilymphocytic globulin therapy in chronic progressive multiple sclerosis

C. E. Reeve, P. Bratty, J. Thomas, 1973, Neurology.

Recognition of human insulin in vitro by T cells from subjects treated with animal insulins.

L. J. Nell, J. Thomas, V. J. Virta, 1985, The Journal of clinical investigation.

Detection of T cells responsive to a vascular growth factor in rheumatoid arthritis

James W. Thomas, G. Miller, X. Zhao, 1994, Immunologic research.

Costimulation of human CD4+ T cells by fibroblast growth factor-1 (acidic fibroblast growth factor).

G. Miller, W. Mckeehan, X. Zhao, 1995, Journal of immunology.

IN VITRO GROWTH OF BASOPHILS CONTAINING THE PHILADELPHIA CHROMOSOME IN THE ACUTE PHASE OF CHRONIC MYELOGENOUS LEUKAEMIA

S. Naiman, J. Thomas, J. Denegri, 1978, British journal of haematology.

Vitamin B12 Content of Normal and Leukaemic Leucocytes

B. Anderson, J. Thomas, 1956, British journal of haematology.

Autoreactive T cells from a type I diabetic recognize multiple class II products.

G. Nepom, G. Miller, M. Reich, 1993, Human immunology.

VH and VL gene usage by murine IgG antibodies that bind autologous insulin.

L. J. Nell, J. Thomas, U. K. Ewulonu, 1990, Journal of immunology.

Effect of therapeutic irradiation on lymphocyte transformation in lung cancer

P. Coy, A. Yuen, J. Thomas, 1971, Cancer.

Identification and partial characterization of ectoATPase expressed by immortalized B lymphocytes.

J. Kapp, K. E. Dombrowski, T. Kirley, 1997, Archives of biochemistry and biophysics.

In vitro cell growth in neonates with Down's syndrome and transient myeloproliferative disorder.

K. Chan, P. Rogers, J. Thomas, 1981, Blood.

H-2-linked Ir gene control of antibody responses to insulin. I. Anti-insulin plaque-forming cell primary responses.

J. Inman, J. Schroer, A. Rosenthal, 1979, Journal of immunology.

Differential effects of intravenous anaesthetic agents on cell-mediated immunity in the Rhesus monkey.

R. Carchman, C. Haisch, F. Thomas, 1982, Clinical and experimental immunology.

"Protective" colostrum in the treatment of patients with advanced breast cancer.

J. F. Sykes, J. Thomas, Z. Óváry, 1960, Archives of surgery.

Defective cell-mediated immunity in carcinoma of the prostate.

P. Lieberman, J. Thomas, G. Jerkins, 1976, Investigative urology.

Adoptive immunotherapy for acute non-lymphocytic leukaemia: a long-term follow up.

J. Thomas, J. Denegri, 2009, Scandinavian journal of haematology.

Epitope analysis of insulin autoantibodies using recombinant Fab

Å. Lernmark, N. Crowther, M. Landin-Olsson, 2005, Clinical and experimental immunology.

Postprandial glucose and insulin responses to meals containing different carbohydrates in normal and diabetic subjects.

B. Hoogwerf, G. Castle, J. Bantle, 1983, The New England journal of medicine.

Use of combinatorial mutagenesis to select for multiply substituted human interleukin-3 variants with improved pharmacologic properties.

J. Shieh, J. Polazzi, M. Abrams, 1999, Experimental hematology.

Fibroblast growth factor-1 (FGF-1) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor-bearing Jurkat T cells.

G. Miller, D. Ballard, V. Byrd, 1999, Journal of immunology.

VH gene structure predicts a large potential anti-insulin repertoire.

J. Thomas, H. Mitchell, 1995, Molecular immunology.

The human immune response to insulin. I. Kinetic and cellular aspects of lymphocyte proliferative responses in diabetics.

L. J. Nell, J. Thomas, 1983, Journal of Immunology.

Metabolic effects of dietary fructose and sucrose in types I and II diabetic subjects.

J. Bantle, J. Thomas, D. Laine, 1986, JAMA.

In vitro lymphocyte responses and skin test reactivity following BCG vaccination.

S. Grzybowski, J. Thomas, D. Clements, 1971, Clinical and experimental immunology.

Acidic fibroblast growth factor in synovial cells.

G. Miller, T. Thieu, V. Byrd, 2000, Arthritis and rheumatism.

Longitudinal epitope analysis of insulin‐binding antibodies in type 1 diabetes

M. Landin-Olsson, C. Torn, T. Hall, 2006, Clinical and experimental immunology.

Observations in immunotherapy of lymphoma and melanoma patients.

J. Thomas, S. Landi, I. Plenderleith, 1975, Clinical and experimental immunology.

ABNORMAL ANTIBODIES AND THEIR DETECTION *

J. Thomas, R. Hasselback, Margaret A. Stuckey, 2007 .

In vitro autologous blast cell sensitization as immunotherapy in acute non-lymphocytic leukemia

J. Thomas, N. Morgan, J. Denegri, 1980, Cancer Immunology and Immunotherapy.

V region diversity in human anti-insulin antibodies. Preferential use of a VHIII gene subset.

J. Thomas, 1993, Journal of immunology.

Cell surface antigens on rat islet tumors.

J. Thomas, V. J. Virta, L. Nell, 1987, Journal of immunology.

Human insulin autoantibody fine specificity and H and L chain use.

J. Thomas, C. Hulbert, L. Nell, 1989, Journal of immunology.

Spectrotypic analysis of antibodies to insulin A and B chains.

M. Beckwith, J. Thomas, L. Nell, 1988, Molecular immunology.

Heterogeneity and specificity of human anti-insulin antibodies determined by isoelectric focusing.

J. Thomas, V. J. Virta, L. Nell, 1985, Journal of immunology.

Evidence for a daily rhythm of plasma HVA in normal controls but not in schizophrenic patients.

O. Wolkowitz, D. Pickar, A. Doran, 1985, Psychopharmacology bulletin.